Dutch Researchers Head SU2C Tumor Profiling Study
August 03, 2012
Dutch Researchers Head SU2C Tumor Profiling Study
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- WUSTL, ICR to Use $4M Komen Grant to Develop Breast Cancer Dx, Screen Treatments
June 4, 2012 / GenomeWeb Daily News - AltheaDx, Compendia Partner on Breast Cancer Assay
December 8, 2010 / GenomeWeb Daily News - ICR, Wellcome Trust, Illumina Launch Clinical Genetic Testing Effort
May 20, 2013 / GenomeWeb Daily News - Theranostics Health to Launch HER Signaling Assay, Marking Firm's First Commercial Test Release
May 3, 2013 / ProteoMonitor - Foundation Medicine to Develop Dx for Agios Cancer Therapeutics
April 4, 2013 / GenomeWeb Daily News